Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i>-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer
Merck Sharp & Dohme LLC
James Chih-Hsin Yang; Dae Ho Lee; Jong-Seok Lee; Yun Fan; Filippo de Marinis; Eiji Iwama; Takako Inoue; Jerónimo Rodríguez-Cid; Li Zhang; Cheng-Ta Yang; Emmanuel de la Mora Jimenez; Jianying Zhou; Maurice Pérol; Ki Hyeong Lee; David Vicente; Eiki Ichihara; Gregory J Riely; Yiwen Luo; Diana Chirovsky; M Catherine Pietanza; Niyati Bhagwati; Shun Lu